← Back to Clinical Trials
Recruiting NCT05389878

NCT05389878 Implementation of a Registry for Patients With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05389878
Status Recruiting
Phase
Sponsor Fondazione Don Carlo Gnocchi Onlus
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 600 participants
Start Date 2022-01-12
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 600 participants in total. It began in 2022-01-12 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pathology registers are scientific research tools for the development of epidemiological and clinical studies and health planning, which allows access to useful elements for planning adequate health services. The Registry collects demographic, clinical and functional data of stroke patients and arises from the need to order and update this information for epidemiological and research purposes, for a better knowledge of this pathology from a rehabilitation point of view and to accelerate the development of new treatments.

Eligibility Criteria

Inclusion Criteria: * Adult patients (over 18 years of age) with ischemic or haemorrhagic stroke, first event or with relapse, time to onset of stroke less than 6 months, signature of informed consent by the patient or family member. Exclusion Criteria: * Patients from Severe Acquired Brain Injuries units and / or with diseases that threaten the patient's life

Contact & Investigator

Central Contact

Francesca Cecchi, MD

✉ fcecchi@dongnocchi.it

📞 +393388627184

Principal Investigator

Francesca Cecchi, MD

PRINCIPAL INVESTIGATOR

IRCCS Fondazione don Carlo Gnocchi

Frequently Asked Questions

Who can join the NCT05389878 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05389878 currently recruiting?

Yes, NCT05389878 is actively recruiting participants. Contact the research team at fcecchi@dongnocchi.it for enrollment information.

Where is the NCT05389878 trial being conducted?

This trial is being conducted at Florence, Italy, Milan, Italy, Parma, Italy, Rovato, Italy.

Who is sponsoring the NCT05389878 clinical trial?

NCT05389878 is sponsored by Fondazione Don Carlo Gnocchi Onlus. The principal investigator is Francesca Cecchi, MD at IRCCS Fondazione don Carlo Gnocchi. The trial plans to enroll 600 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology